CD4 and neoplasm: To further analyse the effect of neo-adjuvant treatment on T-cell numbers we observed the changes in CD3 + , CD4 + and CD8 + T-cells in the matched baseline and day-20 On-treatment tumour biopsy samples of individual patients (Fig. 4).